[Therapy in the myelodysplastic syndrome].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D013949:Thymus Extracts / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D013949:Thymus Extracts; C031407:thymostimulin
Therapie bei Myelodysplasie-Syndrom.